Search

Wakeland Lab's students

L E C T U R E S E R I E S CARDIOMETABOLIC Dr. Vaduganathan received his medical degree from Northwestern University, where he also obtained a master’s degree of public health. He completed residency training at Massachusetts General Hospital and fellowship training in cardiovascular medicine at Brigham and Women’s Hospital. His research is centered on drug development, clinical trials, and the implementation of cardio-renal-metabolic therapies. Dr. Vaduganathan has authored or co-authored

Primarily located in the Advanced Imaging Research Center the Corbin Lab routinely utilizes state-of-the–art small animal imaging systems (MRI, micro-MRI, Optical, micro-CT/SPECT/PET) to characterize rodent models of disease.

Development of B-Lapachone Prodrugs forTherapyAgainst Human Cancer Cells with Elevated NAD(P)H:Quinone Oxidoreductase1Levels Kathryn E. Reinicke,1,2 Erik A. Bey,1,3 Melissa S. Bentle,1,4 JohnJ. Pink,1,3 Stephen T. Ingalls,4,6 Charles L. Hoppel,4,6,7 Rosana I. Misico,8 GiselaM. Arzac,8 Gerardo Burton,8William G. Bornmann,9 Damon Sutton,5 Jinming Gao,5 and David A. Boothman1,3,4 Abstract B-Lapachone, an o-naphthoquinone, induces a novel caspase- and p53-independent apoptotic

Protecting Groups in Organic Synthesis-1 Ready Protecting groups are a sad fact of synthetic chemistry They are usually needed, but rarely desired Many syntheses have stalled because of trouble putting on or removing protecting groups 4 basic questions to address when choosing a P.G.: 1. Can I put it on where and only where I want? 2. Can I take it and only it off? 3. Will it survive all future reaction conditions? 4. Will it

Wakeland Lab's Administration

Michaely Lab teaching

null

Dr. Cowell has built a research program focused on the development of bioinformatics and computational biology methods for studying the immune system and infectious diseases.